Miglino, M <br/><br/>
Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two cases.  [electronic resource] 

 -  Journal of experimental & clinical cancer research : CR  Sep 2006 
 - 321-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0392-9078 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzamides<br/>Drug Monitoring<br/>Female<br/>Fusion Proteins, bcr-abl--genetics<br/>Gene Rearrangement--genetics<br/>Humans<br/>Imatinib Mesylate<br/>Immunoglobulin J-Chains--genetics<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Piperazines--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--therapeutic use<br/>RNA, Neoplasm--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>WT1 Proteins--genetics